Glucagon analogues
US9403894B2 · kind B2 · utility
21Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 23, 2011 |
| Grant date | Aug 2, 2016 |
| Priority date | — |
| Expiry date | Jun 23, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides materials and methods for promoting weight loss or preventing weight gain without affecting glycemic control. In particular, the invention provides novel glucagon analog peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the glucagon-like peptide-1 (GLP-1) receptor as compared to human glucagon.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.